4.4. Analysis.
Comparison 4: Emicizumab 1.5 mg/kg/week prophylaxis versus on‐demand therapy in people without inhibitors, Outcome 4: HRQoL—EQ‐5D‐5L VAS
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.